Michael Seid

Michael Seid

Auto-generated profile, based on publicly available information

Michael Seid

Division of Pulmonary Medicine Cincinnati Children's Hospital Medical Center Cincinnati Ohio USA

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 February 2009 in Arthritis Care & Research
Verified
Journal Article
Open access
PDF file
MSMichael Seid
Michael Seid
LOLisa Opipari
Lisa Opipari
BHBin Huang
Bin Huang
HBHermine I. Brunner
Hermine I. Brunner
DLDaniel J. Lovell
Daniel J. Lovell
Objective: To examine variability in health‐related quality of life (HRQOL) in children with juvenile idiopathic arthritis (JIA) experiencing no or minimal clinical symptoms, and in a subgroup with polyarticular JIA treated with biologic agents for 12 months.Methods: We defined 3 samples using a database of patients ages 2–18 years with JIA (n = 524; patient visits [PV] = 2,354): visits (PV = 2,155) with no or minimal clinical symptoms on at least 1 of 4 measures (active joint count, pain, physician global disease rating, Childhood Health Assessment Questionnaire); visits (PV = 941) with no or minimal symptoms on all 4 measures; and children (n = 31) with polyarticular JIA treated with biologic agents for 12 months. HRQOL was measured using the Pediatric Quality of Life Inventory (PedsQL) and the percentage of patients with suboptimal HRQOL was determined.Results: In PV with a PedsQL score, suboptimal HRQOL by self‐report occurred in 362 (20.6%) PV with at least 1 indicator of minimal symptoms, and in 64 (7.9%) PV with all 4 measures indicating minimal symptoms (519 [25.7%] and 95 [10.7%], respectively, by parent report). For children with polyarticular JIA treated for 12 months with biologic agents, 7 (25.9%) patients by self‐report and 10 (35.7%) patients by parent report were in the suboptimal range of HRQOL.Conclusion: A substantial percentage of patients with JIA who report no or mild clinical symptoms experience suboptimal HRQOL. This is also true for patients with polyarticular JIA treated with biologic agents for 12 months. Although disease activity and clinical symptoms are related to HRQOL, considerable unexplained variation in HRQOL exists. HRQOL needs to be assessed independently regardless of clinical status.

1 March 2014 in JAMA Pediatrics
Verified
Journal Article
Closed access
PDF file
MSMichael Seid
Michael Seid
PMPeter A. Margolis
Peter A. Margolis
LOLisa Opipari-Arrigan
Lisa Opipari-Arrigan
Physicians deliver about half of indicated care, and patients do about half of what it takes to stay healthy, despite the best intentions and tireless efforts o

27 August 2013 in Arthritis Care & Research
Verified
Journal Article
Open access
PDF file
MSMichael Seid
Michael Seid
BHBin Huang
Bin Huang
SNStacey Niehaus
Stacey Niehaus
HBHermine I. Brunner
Hermine I. Brunner
DLDaniel J. Lovell
Daniel J. Lovell
Objective: To examine the degree to which nonmedical factors explain additional variance in parent proxy report and child self‐report of health‐related quality of life (HRQOL) among newly diagnosed children with juvenile idiopathic arthritis (JIA) after accounting for medical factors.Methods: Parents (of children ages 2–16 years; n = 230) and patients (ages >5 years; n = 180) diagnosed within the previous 6 months completed surveys to assess medical (clinical parameters and functional status) and nonmedical (self‐efficacy, coping, barriers to adherence, social support, parental distress, and access to care) factors and HRQOL (Pediatric Quality of Life Inventory Generic Core Scales). Physician‐rated global assessment of disease activity, active joint count, and select laboratory variables (rheumatoid factor, antinuclear antibodies, and erythrocyte sedimentation rate) were recorded.Results: Nonmedical factors, including self‐efficacy, coping with pain, barriers to adherence, social support, and parental distress, explained additional variance in HRQOL total, physical functioning, and psychosocial functioning scales (R2 increases of 6%, 1%, and 13% for parent proxy report and 16%, 7%, and 30% for self‐report, respectively). Parental distress was uniquely associated with parent proxy‐report HRQOL, while child self‐efficacy and social support were uniquely associated with self‐report HRQOL.Conclusion: Nonmedical factors are associated with HRQOL in newly diagnosed patients with JIA after accounting for medical variables, particularly for psychosocial functioning.

19 February 2010 in Journal of Asthma
Verified
Journal Article
Closed access
PDF file
MSMichael Seid
Michael Seid
CLChristine A. Limbers
Christine A. Limbers
KDKimberly Driscoll
Kimberly Driscoll
LOLisa A. Opipari-Arrigan
Lisa A. Opipari-Arrigan
LGLeticia Reyes Gelhard
Leticia Reyes Gelhard
M.M.S.
M.S.
Background. Patient-reported outcomes such as health-related quality of life (HRQOL) are increasingly used as primary endpoints in clinical trials. The Pediatric Quality of Life Inventory™ (PedsQL™) is widely used as a measure of HRQOL and may be a particularly suitable primary outcome in pediatric asthma clinical trials. Objectives. To examine the reliability, validity, and responsiveness to clinical change of the PedsQL™ 4.0 Generic Core Scales and PedsQL™ Asthma Module Asthma Symptoms Scale in a sample of vulnerable children with persistent asthma recruited from Federally Qualified Health Centers. Methods. Children (N = 252; ages 3 to 14 years) with persistent asthma (27% mild, 40.9% moderate, 32.1% severe) and their parents (93.7% mother, 83.3% Hispanic, 76.9% Spanish-speaking, 72.6% less than a high school diploma) enrolled in a clinical trial completed the PedsQL™ 4.0 Generic Core Scales, the PedsQL™ 3.0 Asthma Module Asthma Symptoms Scale, and a measure of asthma symptom frequency (used as an indicator of clinical change) at baseline and 3-month follow-up. Results. The PedsQL™ demonstrated adequate internal consistency reliability and convergent and discriminative validity. Based on intra- and intersubject change, effect sizes, and standard errors of measurement, the PedsQL™ demonstrated responsiveness to clinical change. Conclusions. For both child self-report and parent proxy-report, the PedsQL™ Generic Core Scales Total Scale score and the PedsQL™ Asthma Symptoms Scale are suitable for use as primary asthma clinical trial outcomes.

13 December 2011 in Journal of Pediatric Psychology
Verified
Journal Article
Open access
PDF file
MSMichael Seid
Michael Seid
EDElizabeth J. D'Amico
Elizabeth J. D'Amico
JVJames W. Varni
James W. Varni
JMJennifer K. Munafo
Jennifer K. Munafo
MBMaria T. Britto
Maria T. Britto
LDLynn Darbie
Lynn Darbie
Objective Low-income and minority adolescents are at high risk for poor asthma outcomes, due in part to adherence. We tested acceptability, feasibility, and effect sizes of an adherence intervention for low socioeconomic status (SES) minority youth with moderate- and severe-persistent asthma. Design and Methods Single-site randomized pilot trial: intervention (n = 12; asthma education, motivational interviewing, problem-solving skills training, 1 month cell-phone with tailored text messaging) versus control (n = 14; asthma education; cell-phone without tailored messaging). Calculated effect-sizes of relative change from baseline (1 and 3 months). Results Intervention was judged acceptable and feasible by participants. Participants (12–18 years, mean = 15.1, SD = 1.67) were 76.9% African-American, 80.7% public/no insurance. At 1 and 3 months, asthma symptoms (Cohen's d's = 0.40, 0.96) and HRQOL (PedsQL™; Cohen's d's = 0.23, 1.25) had clinically meaningful medium to large effect sizes. Conclusions This intervention appears promising for at-risk youth with moderate- and severe-persistent asthma.

1 March 2009 in Academic Pediatrics
Verified
Journal Article
Closed access
MSMichael Seid
Michael Seid
LOLisa Opipari-Arrigan
Lisa Opipari-Arrigan
LGLeticia Reyes Gelhard
Leticia Reyes Gelhard
JVJames W. Varni
James W. Varni
KDKimberly Driscoll
Kimberly Driscoll